Get the precise balance of agility, control and expertise with mixed FSP/FSO model solutions
Mixed FSP/FSO model solutions—more than flexible. Precise. Controlled. Just what you need.
Clinical development rarely follows a predictable path. Priorities shift. New challenges emerge. Resource needs fluctuate. Sponsors need an outsourcing model that adapts as quickly as their programs do.
Our mixed FSP/FSO model solutions combine the embedded talent and control of functional service provider (FSP) partnerships with the therapeutic depth and end-to-end capabilities of full-service outsourcing (FSO) arrangements. We create bespoke outsourcing solutions that provide the right balance of agility, control, and expertise —exactly when and where they are needed.
A solution intentionally designed around your specific needs
Today’s clinical environment requires more than choosing between FSP and FSO arrangements. It requires an outsourcing strategy intentionally designed around your goals; one that provides greater control, built-in adaptability and the ability to respond quickly to shifting or unexpected demands—both now and in the future.
With more than 30 years of clinical research experience, the PPD™ clinical research business of Thermo Fisher Scientific delivers bespoke mixed FSP/FSO model solutions that meet you precisely where you are and flex for what’s next—so you can meet your strategic, operational, and financial goals and timelines.
Seamless collaboration. Greater transparency. More efficient execution.
Solutions designed to meet you precisely where you are
Our mixed FSP/FSO model solutions combine the strengths of FSP partnerships and FSO arrangements into customized ecosystems designed specifically around your operational goals, internal capabilities and future growth.
Whether you’re enhancing an existing outsourcing strategy or building one from the ground up, our mixed FSP/FSO model solutions maximize flexibility — allowing you to leverage your internal strengths while accessing targeted support where, when and how it’s needed.
Common approaches include:
A mixed FSP/FSO approach may serve as an effective starting strategy for sponsors transitioning from an insourced to outsourced model to accelerate development timelines. By creating a flexible bridge between existing and future-state operations, mixed FSP/FSO solutions enable sponsors and CRO partners to establish new governance structures, define new ways of working, and evolve operating models while maintaining momentum across ongoing development activities. As a result, sponsors gain the right mix of agility and expertise to meet their goals and timelines as needs shift, demands fluctuate and complexity increases.
Our expertise, by the numbers
Years of clinical and scientific leadership
Employees across the globe
Studies in the past five years
Real-world and market access engagements in the past five years
Expert insights to optimize your outsourcing strategy
Bespoke solutions built around your needs
FAQs
Mixed FSP/FSO model solutions combine elements of functional service provider (FSP) partnerships and full-service outsourcing (FSO) into a customized delivery model designed around your organization’s specific needs.
These bespoke arrangements allow sponsors to retain control over selected functions while leveraging outsourced expertise across others, creating the right balance of flexibility, oversight and operational efficiency.
These solutions are particularly valuable when sponsors want to:
- Retain ownership of strategically important functions
- Add specialized expertise to existing outsourcing arrangements
- Scale resources quickly as priorities shift
- Expand into new therapeutic areas or geographies
- Maintain continuity across portfolios
- Transition between insourced and outsourced operating models
Because the model is highly adaptable, it evolves alongside changing business and clinical development needs.
These solutions help sponsors align outsourcing with their internal capabilities while maintaining flexibility to respond to changing priorities. By combining embedded functional expertise with broader outsourced delivery, sponsors gain greater operational agility, improved resource utilization, stronger governance and the ability to accelerate timelines without sacrificing oversight or quality.
This approach creates greater continuity across programs, stronger operational alignment and more effective decision-making across sponsor and CRO teams. The result is a partnership model designed to help sponsors maintain their control and momentum through increasingly complex business conditions, shifting development priorities and evolving clinical demands, while building a more resilient clinical development ecosystem for the future.
Success starts with the right foundation. We have a proven structure and methodology to support sponsors transitioning to mixed FSP/FSO models—or for those using a mixed FSP/FSO model as a bridge to transition operating structures. And unlike organizations that manage FSP partnerships and FSO independently, our FSP and FSO organizations share talent, systems, processes and infrastructure. This integrated operating model enables seamless collaboration, greater transparency and more efficient execution across every engagement.
Our consultative approach starts at the very beginning of the relationship and focuses on clarifying goals, roles, priorities, and pain points, evaluating internal capabilities and operational gaps, and designing the right balance of embedded support, outsourced delivery, and governance—enabling sponsors to retain control where they want it to leverage their existing strengths and capabilities.
Supported by more than three decades of experience, global infrastructure and the full capabilities of Thermo Fisher Scientific, the world leader in serving science, we design bespoke mixed FSP/FSO model solutions that adapt alongside your organization while delivering the expertise needed to solve increasingly complex clinical development challenges. Each solution is backed by the full force of our training, resources and expertise—and delivered with an uncompromising commitment to quality. And because our experts are located around the world, we bring a nuanced understanding of people, processes and regulatory landscapes to enable rapid deployment across multiple time zones.
At the PPD clinical research business, we work collaboratively with sponsors to develop financial and contracting models that balance flexibility, accountability, and cost control across different activities and stages of development. Embedded functional support, for example, may be best aligned to capacity-based approaches—such as dedicated FTE-, role-based, or time-and-materials resourcing. More centralized or full-service delivery activities may be better suited to outcome- or deliverable-based models, including unit pricing, milestone payments, or defined functional deliverables. These flexible contracting models allow sponsors to scale and adapt resource levels, oversight approaches, delivery structures and financial arrangements in response to evolving workload demands, timelines, risk profiles, and portfolio priorities.
The result is scalable access to specialized expertise and resources as demands evolve. Sponsors operating on aggressive timelines, for example, may rapidly deploy highly skilled staff and services while maintaining continuity, quality and oversight. Or we can bring together functional and therapeutic expertise in highly targeted ways (such as data management experts with deep CAR-T and cell and gene therapy experience) allowing sponsors to access support aligned not only to operational needs, but also to the scientific and clinical realities of their programs. And when needs extend beyond traditional clinical development support, our clients have access to the full spectrum of capabilities of Thermo Fisher Scientific.
More than an outsourcing model — a partnership designed around you
Successful partnerships require more than flexible resourcing. They require aligned priorities, goals, governance and communication. Our work together begins by understanding your organization, evaluating your internal capabilities and identifying where embedded support, outsourced delivery and strategic oversight create the greatest value. This collaborative and consultative approach to partnership ensures we create integrated outsourcing models that evolve as your priorities, portfolios and pipelines evolve.
By bringing together the right combination of functional and therapeutic expertise, operational delivery, technologies, processes, and oversight structures, we build solutions that are responsive to your current needs, but resilient enough to adapt over time. We empower you to move forward with greater confidence today, while building a more resilient clinical development ecosystem for the future.
Build the mixed FSP/FSO model that’s right for your organization — today and in the future. Let’s connect.
- How much does a day of delay in a clinical trial really cost?, June 2024, Applied Clinical Trials, Ken Getz, Executive Director and Professor, Tufts University School of Medicine
- Insights Informing Strategies for Optimizing the Collection of Clinical Trial Data | Therapeutic Innovation & Regulatory Science | Springer Nature Link
- Deloitte, Measuring the return from pharmaceutical innovation, 15th edition March 2025